Ftse Mib
38.592,81
-0,48%
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
NASDAQ
18.196,22
0,70%
Bitcoin
83.349,84
-3,26%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ scPharmaceuticals Inc (SCPH) scPharmaceuticals Inc (SCPH) Notizie

SCPH

scPharmaceuticals (SCPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SCPH
DataOraFonteTitoloSimboloCompagnia
06/03/202522:01GlobeNewswire Inc.scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney DiseaseNASDAQ:SCPHscPharmaceuticals Inc
26/02/202522:01GlobeNewswire Inc.scPharmaceuticals Announces Participation in Two Upcoming Investor ConferencesNASDAQ:SCPHscPharmaceuticals Inc
12/02/202522:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SCPHscPharmaceuticals Inc
05/02/202522:01GlobeNewswire Inc.scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceNASDAQ:SCPHscPharmaceuticals Inc
10/01/202514:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCPHscPharmaceuticals Inc
10/01/202514:00GlobeNewswire Inc.scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:SCPHscPharmaceuticals Inc
31/12/202412:04Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:SCPHscPharmaceuticals Inc
13/11/202423:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SCPHscPharmaceuticals Inc
13/11/202422:01GlobeNewswire Inc.scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:SCPHscPharmaceuticals Inc
28/08/202422:30Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SCPHscPharmaceuticals Inc
13/08/202414:03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SCPHscPharmaceuticals Inc
12/08/202412:05GlobeNewswire Inc.scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive AdvisorsNASDAQ:SCPHscPharmaceuticals Inc
02/02/202418:35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SCPHscPharmaceuticals Inc
08/06/202322:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SCPHscPharmaceuticals Inc
08/06/202322:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SCPHscPharmaceuticals Inc
27/04/202322:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SCPHscPharmaceuticals Inc
27/04/202322:25Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SCPHscPharmaceuticals Inc
22/03/202322:16Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SCPHscPharmaceuticals Inc
22/03/202321:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SCPHscPharmaceuticals Inc
13/03/202321:45Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SCPHscPharmaceuticals Inc
14/02/202322:08Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SCPHscPharmaceuticals Inc
30/11/202205:15TipRanksscPharmaceuticals (SCPH) Gets a Buy from SVB SecuritiesNASDAQ:SCPHscPharmaceuticals Inc
23/11/202222:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SCPHscPharmaceuticals Inc
22/11/202213:31Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:SCPHscPharmaceuticals Inc
11/11/202213:25TipRanksMaxim Group Sticks to Its Buy Rating for scPharmaceuticals (SCPH)NASDAQ:SCPHscPharmaceuticals Inc
10/11/202214:40TipRanksAnalysts’ Top Healthcare Picks: Jazz Pharmaceuticals (JAZZ), scPharmaceuticals (SCPH)NASDAQ:SCPHscPharmaceuticals Inc
10/11/202213:36TipRanksSVB Securities Reaffirms Their Buy Rating on scPharmaceuticals (SCPH)NASDAQ:SCPHscPharmaceuticals Inc
09/11/202222:30Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SCPHscPharmaceuticals Inc
11/10/202212:31TipRanksAnalysts’ Top Healthcare Picks: Aravive (ARAV), scPharmaceuticals (SCPH)NASDAQ:SCPHscPharmaceuticals Inc
10/10/202215:49TipRanksscPharma Slides Even as FDA Approves FuroscixNASDAQ:SCPHscPharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SCPH

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
SFER
Salvatore Ferragamo
BIT
MONC
Moncler
BIT
AMP
Amplifon
BIT
CPR
Davide Campari
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BAMI
Banco BPM
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci